𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thallium-201 uptake in Langerhans cell histiocytosis of bone

✍ Scribed by Z. Bar-Sever; L. P. Connolly; D. Jaramillo; S. T. Treves


Publisher
Springer-Verlag
Year
1996
Tongue
English
Weight
268 KB
Volume
26
Category
Article
ISSN
0301-0449

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Use of indomethacin in Langerhans cell h
✍ Munn, Stephanie E.; Olliver, Lucy; Broadbent, Valerie; Pritchard, Jon πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 53 KB πŸ‘ 2 views

Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie

THE PRESENCE OF CYTOKINES IN LANGERHANS'
✍ DE GRAAF, JAN H.; TAMMINGA, RIENK Y. J.; DAM-MEIRING, ANKE; KAMPS, WILLEM A.; TI πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 788 KB

Langerhans' cell histiocytosis (LCH) is characterized by an accumulation and/or proliferation of cells with a Langerhans' cell (LC) phenotype. The aetiology and pathogenesis of LCH are unknown; it is suggested that LCH is caused by an immunological dysregulation. Production of cytokines is a central